Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
28.58
-0.30 (-1.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Simulations Plus Market Cap
Simulations Plus has a market cap or net worth of $573.52 million as of December 20, 2024. Its market cap has decreased by -27.44% in one year.
Market Cap
573.52M
Enterprise Value
554.27M
1-Year Change
-27.44%
Ranking
Category
Stock Price
$28.58
Market Cap Chart
Since December 1, 1998, Simulations Plus's market cap has increased from $4.50M to $573.52M, an increase of 12,644.89%. That is a compound annual growth rate of 20.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 573.50M | -35.72% |
Dec 29, 2023 | 892.20M | 20.19% |
Dec 30, 2022 | 742.30M | -22.11% |
Dec 31, 2021 | 953.00M | -33.52% |
Dec 31, 2020 | 1.43B | 179.82% |
Dec 31, 2019 | 512.30M | 47.76% |
Dec 31, 2018 | 346.70M | 24.58% |
Dec 29, 2017 | 278.30M | 67.45% |
Dec 30, 2016 | 166.20M | -1.31% |
Dec 31, 2015 | 168.40M | 49.69% |
Dec 31, 2014 | 112.50M | 38.89% |
Dec 31, 2013 | 81.00M | 15.88% |
Dec 31, 2012 | 69.90M | 50.00% |
Dec 30, 2011 | 46.60M | 11.75% |
Dec 31, 2010 | 41.70M | 93.95% |
Dec 31, 2009 | 21.50M | 42.38% |
Dec 31, 2008 | 15.10M | -75.25% |
Dec 31, 2007 | 61.00M | 42.86% |
Dec 29, 2006 | 42.70M | 125.93% |
Dec 30, 2005 | 18.90M | -5.03% |
Dec 31, 2004 | 19.90M | 28.39% |
Dec 31, 2003 | 15.50M | 89.02% |
Dec 31, 2002 | 8.20M | 182.76% |
Dec 31, 2001 | 2.90M | -57.35% |
Dec 29, 2000 | 6.80M | 6.25% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Capricor Therapeutics | 594.29M |
Cross Country Healthcare | 589.54M |
Altimmune | 586.78M |
Varex Imaging | 581.89M |
ORIC Pharmaceuticals | 579.35M |
Surmodics | 569.46M |
InnovAge Holding | 567.56M |
Fulgent Genetics | 560.96M |